Daumantas Matulis, Short CV


Born in Vilnius, Lithuania, 1970





Year of completion




University of Minnesota

Biophysics, postdoctoral associate


University of Minnesota

Biochemistry, Molecular Biology, and Biophysics, Ph.D.


Vilnius University

Biochemistry, 5-year diploma (BS/MS)


University of Oslo

Summer School, Energy Planning and the Environment


Professional experience






Institute of Biotechnology

Head of Laboratory


Johnson&Johnson, Pharmaceutical Research and Development Inc., L.L.C.



3-Dimensional Pharmaceuticals (acquired by Johnson&Johnson)



University of Minnesota

Postdoctoral associate


University of Minnesota

Research Assistant


Institute of Biochemistry

Junior scientist


Submitted 2 patent applications.

Published more than 20 scientific articles in peer-review journals.

Attended more than 40 scientific conferences worldwide, gave invited oral and poster presentations.




  1. Award “Direction-Home” given to Lithuanian scientist selected by an independent Swedish-Lithuanian scientific council, by “Telia Sonera” Inc., Sweden (100.000,00 LT)
  2. Robert Jenness Award by University of Minnesota Department of Biochemistry, Molecular Biology, and Biophysics for the best postdoctoral scientist in 2000 ($1500,00)
  3. Third place in Lithuanian High School Olympics (chemistry), high school student, 1988.


Selected Academic projects and their financial sources


  1. FP6 Marie Curie international reintegration grant, 80.000 Eur. (2004-6).
  2.  “Anticancer drug design”, Lithuanian Science and Studies Foundation, 362.000 Eur. (2005-9).
  3. “Anticancer drug design by structural biothermodynamics”, sponsored by EEA Grants, Norway Grants, 565.000 Eur. (2008-10).


Selected publications


  1. Baranauskiene, L., Matuliene, J., and Matulis, D. 2008. Determination of thermodynamics of carbonic anhydrase acid-unfolding by titration calorimetry. J. Biochem. Biophys. Methods. 70, 1043-1047.
  2. Dudutiene, V., Baranauskiene, L., and Matulis, D. 2007. Benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulfonamides as inhibitors of carbonic anhydrase. Bioorg Med Chem Lett. 17, 3335-3338.
  3. Matulis, D., Kranz, J. K., Salemme, F. R., and Todd, M. J. 2005. Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor. Biochemistry. 44, 5258-5266.
  4. Matulis, D. and Todd, M. 2004. Thermodynamics – structure correlations of sulfonamide inhibitor binding to carbonic anhydrase. In “Biocalorimetry 2“, eds. Ladbury, J.E. and Doyle, M.L. Wiley. 107-132.
  5. Matulis, D., Rouzina, I., and Bloomfield, V. 2002. Thermodynamics of cationic lipid binding to DNA and DNA condensation: Roles of electrostatics and hydrophobicity. J. Am. Chem. Soc. 124, 7331-7342.
  6. Matulis, D. 2001. Thermodynamics of the hydrophobic effect. III. Condensation and aggregation of alkanes, alcohols, and alkylamines. Biophys. Chem. 93, 67-82.




  1. Course “Protein Biophysical Chemistry”, Vilnius University, MS students.
  2. Textbook “Protein Physical Chemistry” in Lithuanian (2008)
  3. Supervised a number of BS and MS student graduation theses.
  4. Course “Biochemistry Laboratory”, University of Minnesota.


Other important academic activities


  1. - written about 15 articles on the subjects of scientific reform, the popularity of science in society, and the support for returning scientists.
  2. - participated in several TV programs and radio shows, including “Ziniu radijas” and Lithuanian national radio concerning science and administrative reforms and popularity.
  3. - participated in the working groups of the Ministry of Economy and the Ministry of Science and Education, where we discuss and improve the documents and priorities of Lithuanian science.
  4. - member of several professional societies – American Chemical Society, Biophysical Society, an expert of the ScanBalt project, where I have participated in over 10 meetings in various Northern European countries and discussed international collaboration of biotechnologists. I have been designated a Lithuanian expert to the EU FP7 “Health” program committee in Brussels.